Cargando…

The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?

As with other chronic conditions, adherence to daily medications remains a challenge for many individuals living with HIV due to structural, behavioral, and social barriers. Unfortunately, high levels of adherence to antiretroviral therapy are required to maintain virologic suppression. Alternative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scarsi, Kimberly K., Swindells, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082990/ https://www.ncbi.nlm.nih.gov/pubmed/33902356 http://dx.doi.org/10.1177/23259582211009011

Ejemplares similares

A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV
por: Bares, Sara H., et al.
Publicado: (2022)

1557 Impact of HIV Pharmacist Reconcilation on Correction of Antiretroviral Prescription Errors Among Hospitalized HIV-Infected Patients
por: Batra, Rishi, et al.
Publicado: (2014)

Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series
por: Kilcrease, Christin, et al.
Publicado: (2022)

Preferences of Patients and Providers in High-Burden Malaria Settings for Long-Acting Malaria Chemoprevention
por: Scarsi, Kimberly K., et al.
Publicado: (2023)

1294. Acceptability and Feasibility of a Pharmacist-led Pre-exposure Prophylaxis Program in the Midwestern United States
por: Bares, Sara, et al.
Publicado: (2018)

Optimizing adherence to antiretroviral therapy
por: Sahay, Seema, et al.
Publicado: (2011)

Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?
por: Brizzi, Marisa, et al.
Publicado: (2023)

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
por: Benning, Lorie, et al.
Publicado: (2020)

Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers
por: Chen, Wanyi, et al.
Publicado: (2023)

Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings
por: Scanlon, Michael L, et al.
Publicado: (2013)

Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States
por: Havens, Joshua P, et al.
Publicado: (2019)

Response to Dong et al.
por: Havens, Joshua P, et al.
Publicado: (2020)

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study
por: Havens, Joshua P, et al.
Publicado: (2023)

Use of peers to improve adherence to antiretroviral therapy: a global network meta-analysis
por: Kanters, Steve, et al.
Publicado: (2016)

Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention
por: Kim, Yeon-Sook
Publicado: (2021)

Interventions to Improve Adherence to Antiretroviral Therapy (ART) in Sub-Saharan Africa: An Updated Systematic Review
por: Damulak, Panmial Priscilla, et al.
Publicado: (2021)

Implementation of Electronic Adherence Monitors and Associated Interventions for Routine HIV Antiretroviral Therapy in Uganda: Promising Findings
por: Haberer, Jessica E., et al.
Publicado: (2022)

Improving antiretroviral therapy adherence in resource‐limited settings at scale: a discussion of interventions and recommendations
por: Haberer, Jessica E., et al.
Publicado: (2017)

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
por: Koester, Kimberly A., et al.
Publicado: (2023)

What makes orphans in Kigali, Rwanda, non-adherent to antiretroviral therapy? Perspectives of their caregivers
por: Kikuchi, Kimiyo, et al.
Publicado: (2014)

Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials
por: Mantsios, Andrea, et al.
Publicado: (2021)

Service delivery interventions to improve adolescents' linkage, retention and adherence to antiretroviral therapy and HIV care
por: MacPherson, Peter, et al.
Publicado: (2015)

Macular arteritis in an HIV-infected patient improving with adherence to antiretroviral therapy
por: Boddé, Elisabeth, et al.
Publicado: (2020)

Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
por: Thoueille, Paul, et al.
Publicado: (2021)

Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV
por: Broekhuis, Jordan M., et al.
Publicado: (2018)

Electronic Health Interventions to Improve Adherence to Antiretroviral Therapy in People Living With HIV: Systematic Review and Meta-Analysis
por: Wang, Ziqi, et al.
Publicado: (2019)

Barriers and facilitators of interventions for improving antiretroviral therapy adherence: a systematic review of global qualitative evidence
por: Ma, Qingyan, et al.
Publicado: (2016)

Improvements to Survey Design from Pilot Testing a Discrete-Choice Experiment of the Preferences of Persons Living with HIV for Long-Acting Antiretroviral Therapies
por: Barthold, Douglas, et al.
Publicado: (2022)

What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda
por: Bukenya, Dominic, et al.
Publicado: (2019)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Long-acting injectable antiretrovirals for HIV treatment and prevention
por: Spreen, William R., et al.
Publicado: (2013)

Barriers to antiretroviral therapy adherence in rural Mozambique
por: Groh, Kate, et al.
Publicado: (2011)

Scientific Production about the Adherence to Antiretroviral Therapy
por: de Oliveira, Regina Célia, et al.
Publicado: (2017)

Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa
por: Reda, Ayalu A., et al.
Publicado: (2012)

Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV
por: Barthold, Douglas, et al.
Publicado: (2023)

Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice
por: Monjok, Emmanuel, et al.
Publicado: (2010)

Tolerising cellular therapies: what is their promise for autoimmune disease?
por: Mosanya, Chijioke H, et al.
Publicado: (2019)

Adherence to oral antiretroviral therapy in Canada, 2010–2020
por: Angel, Jonathan B., et al.
Publicado: (2023)

Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?
por: Kumarasamy, N., et al.
Publicado: (2011)

A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction
por: Lee, Sarah S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_okmsc71l930jm99gbpiqfib2p3